A Retrospective Analysis of Treatment of Covid-19 with Favipiravir
One of the potential therapeutic agents for treating COVID-19 is favipiravir (FPV). This retrospective study compared the treatment of COVID-19 with (FVP group) or without (control group) favipiravir. Demographic characteristics and initial clinical indicators in the two groups were comparable. The...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medical University - Pleven
2022-06-01
|
| Series: | Journal of Biomedical & Clinical Research |
| Subjects: | |
| Online Access: | https://jbcr.arphahub.com/article/34627/download/pdf/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849406651360083968 |
|---|---|
| author | Aigul Utegenova Sholpan Kulzhanova Maiya Konkayeva Zauresh Smagulova Nazira Beisenbieva Gulnara Tuleshova |
| author_facet | Aigul Utegenova Sholpan Kulzhanova Maiya Konkayeva Zauresh Smagulova Nazira Beisenbieva Gulnara Tuleshova |
| author_sort | Aigul Utegenova |
| collection | DOAJ |
| description | One of the potential therapeutic agents for treating COVID-19 is favipiravir (FPV). This retrospective study compared the treatment of COVID-19 with (FVP group) or without (control group) favipiravir. Demographic characteristics and initial clinical indicators in the two groups were comparable. The level of oxygen saturation, respiratory rate, and prevalence of chest pain in the FVP group returned to normal significantly earlier (on the seventh day) compared to the control group (p |
| format | Article |
| id | doaj-art-b4cd01eefd99446098eeb9eb2b2a3816 |
| institution | Kabale University |
| issn | 1313-9053 |
| language | English |
| publishDate | 2022-06-01 |
| publisher | Medical University - Pleven |
| record_format | Article |
| series | Journal of Biomedical & Clinical Research |
| spelling | doaj-art-b4cd01eefd99446098eeb9eb2b2a38162025-08-20T03:36:18ZengMedical University - PlevenJournal of Biomedical & Clinical Research1313-90532022-06-01151747810.2478/jbcr-2022-001034627A Retrospective Analysis of Treatment of Covid-19 with FavipiravirAigul UtegenovaSholpan KulzhanovaMaiya KonkayevaZauresh SmagulovaNazira BeisenbievaGulnara TuleshovaOne of the potential therapeutic agents for treating COVID-19 is favipiravir (FPV). This retrospective study compared the treatment of COVID-19 with (FVP group) or without (control group) favipiravir. Demographic characteristics and initial clinical indicators in the two groups were comparable. The level of oxygen saturation, respiratory rate, and prevalence of chest pain in the FVP group returned to normal significantly earlier (on the seventh day) compared to the control group (phttps://jbcr.arphahub.com/article/34627/download/pdf/favipiravirCOVID-19SARS-CoV-2antiviral thera |
| spellingShingle | Aigul Utegenova Sholpan Kulzhanova Maiya Konkayeva Zauresh Smagulova Nazira Beisenbieva Gulnara Tuleshova A Retrospective Analysis of Treatment of Covid-19 with Favipiravir Journal of Biomedical & Clinical Research favipiravir COVID-19 SARS-CoV-2 antiviral thera |
| title | A Retrospective Analysis of Treatment of Covid-19 with Favipiravir |
| title_full | A Retrospective Analysis of Treatment of Covid-19 with Favipiravir |
| title_fullStr | A Retrospective Analysis of Treatment of Covid-19 with Favipiravir |
| title_full_unstemmed | A Retrospective Analysis of Treatment of Covid-19 with Favipiravir |
| title_short | A Retrospective Analysis of Treatment of Covid-19 with Favipiravir |
| title_sort | retrospective analysis of treatment of covid 19 with favipiravir |
| topic | favipiravir COVID-19 SARS-CoV-2 antiviral thera |
| url | https://jbcr.arphahub.com/article/34627/download/pdf/ |
| work_keys_str_mv | AT aigulutegenova aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT sholpankulzhanova aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT maiyakonkayeva aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT zaureshsmagulova aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT nazirabeisenbieva aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT gulnaratuleshova aretrospectiveanalysisoftreatmentofcovid19withfavipiravir AT aigulutegenova retrospectiveanalysisoftreatmentofcovid19withfavipiravir AT sholpankulzhanova retrospectiveanalysisoftreatmentofcovid19withfavipiravir AT maiyakonkayeva retrospectiveanalysisoftreatmentofcovid19withfavipiravir AT zaureshsmagulova retrospectiveanalysisoftreatmentofcovid19withfavipiravir AT nazirabeisenbieva retrospectiveanalysisoftreatmentofcovid19withfavipiravir AT gulnaratuleshova retrospectiveanalysisoftreatmentofcovid19withfavipiravir |